STK11 and hepatocellular carcinoma: Even hepatocytic knockdown of LKB1 seems sufficient to abolish effects of circLARP1B absence in HCC (Figure 10a–e; Figure S9c–j, Supporting Information), it is possible that the other mRNAs sensitive to circLARP1B and HNRNPD may also take part in the regulatory effects of circLARP1B to some degree.